Introduction and first validation of EpiTrack Junior, a screening tool for the assessment of cognitive side effects of antiepileptic medication on attention and executive functions in children and adolescents with epilepsy

Epilepsy and Behavior

Volumn 19, Issue 1, 2010, Pages 55-64

  Helmstaedter, C ^a   Schoof, K ^a   Rossmann, T ^b   Reuner, G ^c   Karlmeier, A ^d   Kurlemann, G ^e  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d BHZ Vogtareuth   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Antiepileptic drugs; Attention; Cognitive side effects; Epilepsy; Executive functions; Neuropsychology; Screening; Working memory

Indexed keywords

ETHOSUXIMIDE; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; SULTIAME; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; ATTENTION; CHILD; COGNITIVE DEFECT; CONTROLLED STUDY; EPILEPSY; EXTERNAL VALIDITY; FACTORIAL ANALYSIS; FEBRILE CONVULSION; FEMALE; FLUENCY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRESCHOOL CHILD; RESPONSE VARIABLE; SCHOOL CHILD; SCREENING TEST; TEST RETEST RELIABILITY; TONIC CLONIC SEIZURE; VALIDATION STUDY; WORKING MEMORY;

ADOLESCENT; AGE FACTORS; ANALYSIS OF VARIANCE; ANTICONVULSANTS; ATTENTION; CHILD; COGNITION DISORDERS; EPILEPSY; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 77956615255     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2010.06.042     Document Type: Article

References (41)

1. Bourgeois B.F., Prensky A.L., Palkes H.S., Talent B.K., Busch S.G. Intelligence in epilepsy: a prospective study in children. Ann Neurol 1983, 14:438-444.
2. Camfield C.S., Camfield P.R. Long-term social outcomes for children with epilepsy. Epilepsia 2007, 48(Suppl. 9):3-5.
3. Wakamoto H., Nagao H., Hayashi M., Morimoto T. Long-term medical, educational, and social prognoses of childhood-onset epilepsy: a population-based study in a rural district of Japan. Brain Dev 2000, 22:246-255.
4. Elger C.E., Helmstaedter C., Kurthen M. Chronic epilepsy and cognition. Lancet Neurol 2004, 3:663-672.
5. Gilliam F.G., Fessler A.J., Baker G., Vahle V., Carter J., Attarian H. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 2004, 62:23-27.
6. Uijl S.G., Uiterwaal C.S., Aldenkamp A.P., et al. Adjustment of treatment increases quality of life in patients with epilepsy: a randomized controlled pragmatic trial. Eur J Neurol 2009, 16:1173-1177.
7. Bootsma H.P., Ricker L., Diepman L., et al. Long-term effects of levetiracetam and topiramate in clinical practice: a head-to-head comparison. Seizure 2008, 17:19-26.
8. Bootsma H.P., Ricker L., Hekster Y.A., et al. The impact of side effects on long-term retention in three new antiepileptic drugs. Seizure 2009, 18:327-331.
9. Meador K.J., Baker G.A., Browning N., et al. Cognitive function at 3years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009, 360:1597-1605.
10. Hermann B., Jones J., Sheth R., Dow C., Koehn M., Seidenberg M. Children with new-onset epilepsy: neuropsychological status and brain structure. Brain 2006, 129:2609-2619.
11. Dunn D.W., Kronenberger W.G. Childhood epilepsy, attention problems, and ADHD: review and practical considerations. Semin Pediatr Neurol 2005, 12:222-228.
12. Bourgeois B.F. Antiepileptic drugs, learning, and behavior in childhood epilepsy. Epilepsia 1998, 39:913-921.
13. Loring D.W., Meador K.J. Cognitive side effects of antiepileptic drugs in children. Neurology 2004, 62:872-877.
14. Helmstaedter C. Neuropsychological complaints, deficits and difficulties in every day life. Comprehensive care for people with epilepsy 2001, 293-306. John Libbey, London. M. Pfäfflin RTF, R. Thorbecke, U. Specht, P. Wolf (Eds.).
15. Aldenkamp A.P., De Krom M., Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 2003, 44(Suppl. 4):21-29.
16. Aldenkamp A.P., Vermeulen J. Effects of antiepileptics drugs on cognition. Rev Neurol 2002, 34:851-856.
17. Kwan P., Brodie M.J. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001, 357:216-222.
18. Lagae L. Cognitive side effects of anti-epileptic drugs: the relevance in childhood epilepsy. Seizure 2006, 15:235-241.
19. Loring D.W., Marino S., Meador K.J. Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev 2007, 17:413-425.
20. Meador K.J. Cognitive side effects of antiepileptic drugs. Can J Neurol Sci 1994, 21:S12-S16.
21. Ortinski P., Meador K.J. Cognitive side effects of antiepileptic drugs. Epilepsy Behav 2004, 5(Suppl. 1):S60-S65.
22. Drane D.L., Meador K.J. Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav 2002, 3:49-53.
23. Helmstaedter C., Lutz M.T. EpiTrack: Veränderungssensitives kognitives Skreening zur Qualitäts- und Outcomekontrolle der Epilepsiebehandlung 2005, UCB GmbH, Kerpen.
24. Lutz M.T., Helmstaedter C. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy. Epilepsy Behav 2005, 7:708-714.
25. Fritz N., Elger C., Helmstaedter C. Effects of lamotrigine and oxcarbazepine on seizures, cognition, mood and health-related quality of life in patients with untreated epilepsy [abstract]. Epilepsia 2006, 47:157.
26. Fritz N., Glogau S., Hoffmann J., Rademacher M., Elger C.E., Helmstaedter C. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav 2005, 6:373-381.
27. Fritz N.E., Elger C.E., Helmstaedter C. Effects of add-on treatment with topiramate or levetiracetam on cognition and health related quality of life for patients with epilepsy. Epilepsia 2005, 46:106-107.
28. Kockelmann E., Elger C.E., Helmstaedter C. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Res 2003, 54:171-178.
29. Kockelmann E., Elger C.E., Helmstaedter C. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication. Epilepsy Behav 2004, 5:716-721.
30. Helmstaedter C., Witt J.A. The effects of levetiracetam on cognition: a non-interventional surveillance study. Epilepsy Behav 2008, 13:642-649.
31. Helmstaedter C., Witt J.A. Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial. Epilepsy Behav 2010, 18:74-80.
32. Baron I.S. Neuropsychological evaluation of the child 2004, Oxford Univ. Press, New York.
33. Lehrl S., Fischer B. Kurztest für cerebrale Insuffizienz 1997, Hogrefe, Göttingen.
34. Reitan R.M. The relation of the trail making test to organic brain damage. J Consult Psychol 1955, 19:393-394.
35. Chapuis F. Labyrinthtest 1992, Hogrefe, Göttingen.
36. Horn W. Leistungsprüfungssystem Manual 1983, Hogrefe, Göttingen.
37. Wechsler D. Hamburger Wechsler Intelligenztest für Erwachsene Revision 1991, Huber-Verlag, Bern.
38. Helmstadter C. EpiTrack Junior: Veränderungssensitives kognitives Skreenng zur Qualitäts- und Erfolgskontrolle der Epielpsiebehandlung bei Kindern und Jugendlichen 2008, UCB GmbH, Monheim.
39. Taylor J., Kolamunnage-Dona R., Marson A.G., Smith P.E., Aldenkamp A.P., Baker G.A. Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment?. Epilepsia 2010, 51:48-56.
40. Fritz N., Baumann M., Schubert M., Hoffmann G.F., Pietz J., Reuner G. EpiTrack-Junior®: Validierung eines Screeningverfahrens für Aufmerksamkeit und Exekutivfunktionen bei pädiatrischen Patienten mit Absenceepilepsie [abstract] 2010, Jahrestagung der Deutschen Sektion der Internationalen Liga gegen Epilepsie, Wiesbaden.
41. Park S.P., Kwon S.H. Cognitive effects of antiepileptic drugs. J Clin Neurol 2008, 4:99-106.